Stock ADXS AYALA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Ayala Pharmaceuticals, Inc.

Equities

ADXS

US0076244062

Market Closed - OTC Markets
Other stock markets
 01:35:48 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.665 USD +19.82% Intraday chart for Ayala Pharmaceuticals, Inc. +16.26% -0.30%
Apr. 16 Ayala Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 16 Ayala Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Ayala Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e1751084c658aa3d9a.sZMbcQWF9IaDQDGcAJo0Mn2RH5l21RhqEbMHyZRD65s.6_RVFl21tqvqN0upYttNAUnYc_gPligpQetdgKAhnvnFvlAfaMirxdo6CQ~0b3cc97060425a7fe021c66528151354

Analyst Recommendations on Ayala Pharmaceuticals, Inc.

North American Morning Briefing : Stocks Futures Steady on Rates Optimism DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh DJ
ADVAXIS : Alliance Global Adjusts Advaxis' Price Target to $2.25 From $5, Maintains Buy Rating MT
Advaxis Announces Updated Data at ASCO from a Phase 2 Study of AXAL in Advanced Cervical Cancer Showing Promising Survival Rates Consistent with Earlier Reports CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.665
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ayala Pharmaceuticals, Inc.

Alliance Global Partners

Chiffre d''affaires - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ADXS Stock
  4. Consensus Ayala Pharmaceuticals, Inc.